Cancers Upcoming Events Announce Your Event Here

15–16 February 2018 13th Annual Biomarkers Congress

Manchester, UK

Oxford Global is proud to present the 13th Annual Biomarkers Congress to be held on 15-16 February 2018 in Manchester.

The congress covers novel developments in biomarker discovery and validation, translation into the clinic, personalised healthcare, Big data management, clinical diagnostics development. Key therapeutic focus areas include Immuno Oncology, Neuroscience, Respiratory, Metabolic and Cardiovascular Diseases.

Attended by over 300 biomarker experts, congress will include representatives from the companies including Bayer, Roche, Merck, UCB, Pfizer. The high quality and outstanding interactive programme includes 2 pre-event webinars, 50 expert presentations, a workshop and 8 round table discussions.

Do not miss out on the latest developments in biomarker innovations, state of the art technologies, and drivers into biomarker development such as precision medicine, immuno-assays and screening processes, histology, immunohistochemistry, big data analytics, new technologies in translation and the prediction of patient population.

View the Agenda here: http://bit.ly/2v4APod

Free Pre-Congress Live Webinar

Predictive and Efficacy Biomarkers in Cancer Research
Tuesday 28th November 2018 | 10am GMT
Hosted by Mattias Bergqvist, VP Clinical Development, Biovica International and Sue Burchill, Professor of Adolescent and Paediatric Cancer Research, Leeds Institute of Cancer and Pathology.

Register today for free: http://bit.ly/2xT7TR9

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk

http://bit.ly/2v4APod

16–17 April 2018 5th Annual Biosimilars & Biobetters Congress

London, UK

Oxford Global Conferences are proud to present the 5th Annual Biosimilars & Biobetters Congress  co-located with the 11th Annual Proteins & Antibodies Congress and the 5th Annual Peptides Congress, taking place on the 16-17 April 2018 in London.

Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions

Over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics

Two-day interactive conference addressing the following topics:

  • Market Access Strategies, Opportunities, Clinical Development and Commercial Challenges
  • Developing Biosimilars and Biobetters – Manufacturing and Bio-analytics 

View Agenda here: http://bit.ly/2eFkKL6

Free Pre-Congress Live Webinars

Biosimilars: Everyday Practice, Manufacturing Pre-Clinical Trials
Hosted by Katalin Egyed, International Oncology and Onco-biotechnology Business Unit Manager, EGIS Pharmaceuticals and Rafał Derlacz, Senior Project Manager, Polpharma.
Wednesday 7th February 2018 | 10am GMT

Register today for free: http://bit.ly/2xNJGbG

Biosimilars: The Cancer Patient Perspective
Hosted by Lydia Makaroff, Director, European Cancer Patient Coalition
Tuesday 13th February 2018 | 10am GMT

Register today for free: http://bit.ly/2j1vAAf

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk

https://www.biosimilars-congress.com/

24–25 May 2018 3rd Annual Advances in Immuno-Oncology Congress

London, UK

Oxford Global is proud to present the 3rd Annual Advances in Immuno-Oncology Congress taking place on 24–25 May 2018 in London, UK, featuring over 50 presentations in a revamped conference programme that ensures you will benefit from the latest case studies and high-level scientific debate.

Discussion ranges across a variety of therapeutic strategies, from the discovery of combination therapies to vaccines to checkpoint inhibitors. Further talks look at genomic approaches to cancer immunotherapy and the impact of growing microbiome research on immuno-oncology.

6 interactive streams:

  • Discovery of Immuno-Oncology Therapies
  • Translational Immuno-Oncology
  • Genomics in Cancer Immunotherapy and Precision Medicine
  • Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
  • Immuno-Oncology Therapeutics Approaches: Clinical Research and Clinical Trials
  • Microbiome in Immuno-Oncology

View the Agenda here: http://bit.ly/2oJlVB7

Key Speakers include Chief Executives and Directors from AstraZeneca, Merck, GlaxoSmithKline, Glycostem and many more. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

Free Pre-Congress Live Webinars

Novel Checkpoint Inhibitors & Strategies for Combined Modality Treatment
Hosted by Geert Mudde, Founder and Chief Scientific Officer, TYG Oncology Ltd.
Register today, for free: http://bit.ly/2mGZNmO

Personalised Medicine and Immuno-Oncology
Hosted by Agnete Fredriksen, Chief Scientific Officer, Vaccibody
Register today, for free: http://bit.ly/2rigNFh

Can’t make the dates? Still register and a copy of the webinar recording can be sent to you.

For further information about the programme, prices & discounts please contact a.fernandez@oxfordglobal.co.uk

http://bit.ly/2oJlVB7

7–8 June 2018 Oxford Global’s 19th Annual Drug Discovery Summit

Berlin, Germany

Join Oxford Global’s 19th Annual Drug Discovery Summit on the 7- 8th June 2018 in Berlin, Germany to explore the latest innovations pushing industry to new heights. This congress will cover such areas as innovation, enabling technologies, new modalities and novel drug targets as well as covering key areas such as phenotypic screening, genome based drug discovery and small molecule drug discovery.

Bringing together over 300 senior level peers, the congress is once again co-located with our 6th Annual Discovery Chemistry and Drug Design Congress. Delegates can expect to hear updates on discovery, medicinal and computational chemistry as well as medicinal chemistry in drug design. New for 2018 we’ll be including deep dive sessions on DNA encoded libraries as well as presentations on data visualisation, protein-protein interactions and protein degradation.

VIEW AGENDA: http://bit.ly/2mqWK5m

Drug Discovery Summit Streams:

  • Drug Discovery Innovation and Strategies
  • Successful Phenotypic Drug Discovery and Other High Content Screening Tools
  • Novel Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology
  • Genome Based Drug Discovery, Screening, Imaging & Target Discovery

Discovery Chemistry & Drug Design Congress Streams:

  • Discovery Chemistry, Medicinal and Computational Chemistry
  • Drug Discovery Enabled Technologies; DNA Encoded Libraries
  • Medicinal Chemistry and Drug Design: Novel Approaches

https://www.drugdiscovery-summit1.com/

7–8 June 2018 2nd Annual Microbiome Discovery and Development Congress

Berlin, Germany

Oxford Global is proud to present the 2nd Annual Microbiome Discovery and Development Congress, taking place on the 7-8th June 2018 in Berlin, Germany. The conference showcases world-class senior industry experts presenting case studies on the most exciting issues in the microbiome field, covering novel strategies in microbiome research, the latest therapeutic trends, and the challenges and opportunities involved in commercialising microbiome therapeutics.

View Agenda: http://bit.ly/2BOsODK

The congress will cover 2 areas focusing on:

  • Novel Strategies & Technologies for Microbiome Drug Discovery
  • Therapeutic Potential of the Microbiome
  • New for 2018! Workshop on commercialising microbiome therapeutics.

Further sessions will focus on subjects including bioinformatics, translational modelling, genomic approaches, IP concerns, investment in the microbiome, the gut-brain axis and autoimmune disorders. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

2018 Microbiome Webinar:      
Microbiome-Directed Therapeutics to tackle metabolic disorders        
Hosted by Sandrine Claus, Chief Scientific Officer, LNC Therapeutics     
Register for Free Now: http://bit.ly/2j0IqvO

For more information about our programme and to register for the congress, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk.

http://bit.ly/2BOsODK

11–13 October 2018 Melbourne International Joint Breast Congress - ASBD, 4th CoBrCa & BreastSurgANZ

Melbourne, Australia

Melbourne International Breast Congress - held jointly with Australasian Society for Breast Disease (ASBD), 4th World Congress on Controversies in Breast Cancer (CoBrCa) & Breast Surgeons of Australia & New Zealand (BreastSurgANZ) - Melbourne, Australia, October 11-13, 2018. As the main congress in the field of breast diseases in the Asia-Pacific region in 2018, it shouldn’t be missed! It will directly address key issues facing clinicians in their daily practice, including medical oncology, surgery, radiation oncology, pathology, reconstruction, breast imaging, & more. The collaboration will create a multi-faceted congress of interest to all involved in the treatment of breast disease.

http://melbournebreast2018.org/

Back to Top